Format

Send to

Choose Destination
See comment in PubMed Commons below
Adv Ther. 2016 Jan;33(1):1-28. doi: 10.1007/s12325-015-0275-4. Epub 2016 Jan 25.

25 Years of Contrast-Enhanced MRI: Developments, Current Challenges and Future Perspectives.

Author information

1
MR and CT Contrast Media Research, Bayer HealthCare, Berlin, Germany.
2
Global Medical Affairs Radiology, Bayer HealthCare, Berlin, Germany.
3
Saarland University Hospital, Homburg, Germany.
4
Medical Imaging, Coimbra Hospital and University Centre, Coimbra, Portugal.
5
Radiology, Medical Physics and Biomedical Engineering, University of Wisconsin, Madison, WI, USA.
6
Radiology and Neurological Surgery, University of South California, Keck School of Medicine, USC University Hospital, Los Angeles, CA, USA.
7
College of Medicine, Seoul National University Hospital, Seoul, South Korea.
8
Radiology, Utrecht University Medical Center, Utrecht, The Netherlands.
9
Radiology, Xuan Wu Hospital, Capital Medical University, Beijing, People's Republic of China.
10
Radiology, Ludwig-Maximilians University, University Hospitals, Munich, Germany.
11
Radiology, Weill Cornell Medical College, New York, NY, USA.
12
Columbia College of Physicians and Surgeons, New York, NY, USA.
13
Radiology, University of Bonn, Bonn, Germany.
14
Diagnostic Radiology, Yale School of Medicine, New Haven, CT, USA.
15
Graduate Division of Medical Health Sciences, Graduate School of Komazawa University, Tokyo, Japan.
16
MR and CT Contrast Media Research, Bayer HealthCare, Berlin, Germany. hubertus.pietsch@bayer.com.

Abstract

In 1988, the first contrast agent specifically designed for magnetic resonance imaging (MRI), gadopentetate dimeglumine (Magnevist(®)), became available for clinical use. Since then, a plethora of studies have investigated the potential of MRI contrast agents for diagnostic imaging across the body, including the central nervous system, heart and circulation, breast, lungs, the gastrointestinal, genitourinary, musculoskeletal and lymphatic systems, and even the skin. Today, after 25 years of contrast-enhanced (CE-) MRI in clinical practice, the utility of this diagnostic imaging modality has expanded beyond initial expectations to become an essential tool for disease diagnosis and management worldwide. CE-MRI continues to evolve, with new techniques, advanced technologies, and novel contrast agents bringing exciting opportunities for more sensitive, targeted imaging and improved patient management, along with associated clinical challenges. This review aims to provide an overview on the history of MRI and contrast media development, to highlight certain key advances in the clinical development of CE-MRI, to outline current technical trends and clinical challenges, and to suggest some important future perspectives.

FUNDING:

Bayer HealthCare.

KEYWORDS:

Body imaging; Contrast enhancement; Gadolinium; MRI; Multimodality imaging; Relaxivity

PMID:
26809251
PMCID:
PMC4735235
DOI:
10.1007/s12325-015-0275-4
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Springer Icon for PubMed Central
    Loading ...
    Support Center